SHEILA RAZMZAN: Open Payments
NPI 1861899239 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$141 in 6 payments from 5 companies in 2025. Trend: 2023 $458 · 2024 $319 · 2025 $141
Food & beverage: $141
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 1 | $35 |
| Shionogi Inc | 2 | $30 |
| Medtronic, Inc. | 1 | $27 |
| AtriCure, Inc. | 1 | $24 |
| Haemonetics Corporation | 1 | $24 |
Products named: ZERBAXA, Fetroja, TRANSORB, ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM, TEG6S HEMOSTASIS SYSTEM.
Industry payments across TX — which companies pay providers there.
